Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 8

Results: 15

Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1137, doi. 10.1007/s00262-007-0444-7

By:

Kondadasula, Sri Vidya;
Varker, Kimberly A.;
Lesinski, Gregory B.;
Benson, Jr., Don M.;
Lehman, Amy;
Olencki, Thomas;
Monk, J. Paul;
Kendra, Kari;
Carson, III, William E.

Publication type:

Article

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1115, doi. 10.1007/s00262-007-0441-x

By:

Osada, Takuya;
Chong, Gabriel;
Tansik, Robert;
Hong, Timothy;
Spector, Neil;
Kumar, Rakesh;
Hurwitz, Herbert I.;
Dev, Inderjit;
Nixon, Andrew B.;
Lyerly, H. Kim;
Clay, Timothy;
Morse, Michael A.

Publication type:

Article

The neoplastically transformed (CD30<sup>hi</sup>) Marek’s disease lymphoma cell phenotype most closely resembles T-regulatory cells.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1253, doi. 10.1007/s00262-008-0460-2

By:

Shack, L. A.;
Buza, J. J.;
Burgess, S. C.

Publication type:

Article

Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1125, doi. 10.1007/s00262-007-0442-9

By:

Hamilton, Duane H.;
Bretscher, Peter A.

Publication type:

Article

Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1215, doi. 10.1007/s00262-008-0456-y

By:

Kanduc, Darja;
Tessitore, Luciana;
Lucchese, Guglielmo;
Kusalik, Anthony;
Farber, Emanuel;
Marincola, Francesco M.

Publication type:

Article

Delivery of mengovirus-derived RNA replicons into tumoural liver enhances the anti-tumour efficacy of a peripheral peptide-based vaccine.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1161, doi. 10.1007/s00262-007-0448-3

By:

Couty, Jean-Pierre;
Crain, Anne-Marie;
Gerbaud, Sylvie;
Labasque, Marilyne;
Marchiol, Carmen;
Fradelizi, Didier;
Boudaly, Sarah;
Guettier, Catherine;
Vignuzzi, Marco;
Van Der Werf, Sylvie;
Escriou, Nicolas;
Viguier, Mireille

Publication type:

Article

Recognition of naturally processed and ovarian cancer reactive CD8<sup>+</sup> T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1185, doi. 10.1007/s00262-008-0450-4

By:

Matsuzaki, Junko;
Feng Qian;
Luescher, Immanuel;
Lele, Shashikant;
Ritter, Gerd;
Shrikant, Protul A.;
Gnjatic, Sacha;
Old, Lloyd J.,3;
Odunsi, Kunle

Publication type:

Article

Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1263, doi. 10.1007/s00262-008-0451-3

By:

Simmons, Andrew D.;
Moskalenko, Marina;
Creson, Jennifer;
Jianmin Fang;
Yi, Saili;
VanRoey, Melinda J.;
Allison, James P.;
Jooss, Karin

Publication type:

Article

CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1151, doi. 10.1007/s00262-007-0447-4

By:

Rakhmilevich, Alexander L.;
Buhtoiarov, Ilia N.;
Malkovsky, Miroslav;
Sondel, Paul M.

Publication type:

Article

Anti-angiogenic active immunotherapy: a new approach to cancer treatment.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1105, doi. 10.1007/s00262-008-0452-2

By:

Jianping Pan;
Pengfeng Jin;
Jie Yan;
Kabelitz, Dieter

Publication type:

Article

TGFβ secreted by B16 melanoma antagonizes cancer gene immunotherapy bystander effect.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1197, doi. 10.1007/s00262-008-0453-1

By:

Penafuerte, Claudia;
Galipeau, Jacques

Publication type:

Article

Serum antibodies against Saccharomyces cerevisiae: a new prognostic indicator in metastatic renal-cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1207, doi. 10.1007/s00262-008-0454-0

By:

Ramoner, Reinhold;
Rahm, Andrea;
Gander, Hubert;
Stollenwerk, Björn;
Falkensammer, Claudia;
Leonhartsberger, Nicolai;
Thurnher, Martin

Publication type:

Article

Use of radiolabeled monoclonal antibody to enhance vaccine-mediated antitumor effects.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1173, doi. 10.1007/s00262-008-0449-x

By:

Chakraborty, Mala;
Gelbard, Alexander;
Carrasquillo, Jorge A.;
Yu, Sarah;
Mamede, Marcelo;
Paik, Chang H.;
Camphausen, Kevin;
Schlom, Jeffrey;
Hodge, James W.

Publication type:

Article

Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1).

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1225, doi. 10.1007/s00262-008-0457-x

By:

Jung Hee Woo;
Bour, Sarah H.;
Dang, Tony;
Yu-Jen Lee;
Seong Kyu Park;
Andreas, Elissa;
Soo Hyun Kang;
Jen-Sing Liu;
Neville, Jr., David M.;
Frankel, Arthur E.

Publication type:

Article

The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-δ dependent manner.

Published in:

Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1241, doi. 10.1007/s00262-008-0458-9

By:

Hampson, Peter;
Kavanagh, Dean;
Smith, Emily;
Keqing Wang;
Lord, Janet M.;
Rainger, G. Ed

Publication type:

Article